The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BeiGene
Phase 3 zanubrutinib (BGB-3111) vs bendamustine + rituximab (BR) in patients (pts) with treatment-naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
 
Peter Hillmen
Honoraria - Abbvie; Acerta Pharma; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; Gilead Sciences; Janssen
Speakers' Bureau - Abbvie; Acerta Pharma; Gilead Sciences; Janssen
Research Funding - Abbvie; Gilead Sciences; GlaxoSmithKline; Janssen; Pharmacyclics; Roche
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; Celgene; Cell Therapeutics; Genentech/Roche; Juno Therapeutics; Millennium; Pharmacyclics; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); ADC Therapeutics (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Abbvie; Celgene; Genentech/Roche; Juno Therapeutics; Millennium; Seagen
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen
Speakers' Bureau - Gilead Sciences
Research Funding - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen; Novartis
 
Tadeusz Robak
Honoraria - BeiGene
Consulting or Advisory Role - BeiGene
Research Funding - BeiGene
 
Carol Marimpietri
No Relationships to Disclose
 
Aileen Cohen
Employment - BeiGene
Consulting or Advisory Role - Acerta Pharma; BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Constantine Si Lun Tam
No Relationships to Disclose